Your session is about to expire
← Back to Search
VNS for Epilepsy (VNSAIG Trial)
VNSAIG Trial Summary
This trial is studying whether vagal nerve stimulation (VNS) for epilepsy affects bowel habits and the gut microbiome. VNS is a neurosurgical procedure where an impulse generator is placed near the vagus nerve in the neck.
VNSAIG Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowVNSAIG Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.VNSAIG Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have previously been treated with VNS.I have a heart rhythm problem or a device like a pacemaker.I have taken steroids in the last month or might during the study.I have not taken immunomodulators in the last month.I have undergone chemotherapy in the past.I am getting a VNS device for my epilepsy for the first time.I am not currently pregnant.I have had cancer in the past.I have not taken any cholinergic or anticholinergic medication in the last month.
- Group 1: Patients undergoing device implantation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there opportunities for new participants to join this experiment?
"According to clinicaltrials.gov this medical study is still recruiting patients as of today. The trial was first made publicly available on April 1st 2021, and the most recent update happened on November 7th 2022."
Could I potentially be part of this research program?
"To participate in this clinical trial, individuals must be between 0 and 60 years old while suffering from IBD. Around 30 candidates will eventually be admitted to the study."
What is the cap on the number of participants enrolled in this experiment?
"Indeed, according to clinicaltrials.gov, this trial is currently seeking participants; it was first published on April 1st 2021 and the last status update occurred on November 7th 2022. The study plans to recruit 30 individuals at two distinct sites."
Is this research open to participants aged 75 and older?
"This clinical trial has set the minimum age requirement for enrollment at 0 and the maximum age limit is 60."
Share this study with friends
Copy Link
Messenger